scPharmaceuticals (NASDAQ:SCPH) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.38) by 7.89 percent. This is unchanged from the same period last year. The company reported quarterly sales of $12.20 million which beat the analyst consensus estimate of $12.08 million by 0.96 percent. This is a 100.13 percent increase over sales of $6.10 million the same period last year.